Save
International collaborative research initiative on chronic subdural haematoma (iCORIC); planning the future of CSDH trials and management
EANS Academy. Edlmann E. Sep 27, 2019; 276153; EP05055
Mrs. E Edlmann
Mrs. E Edlmann

Access to this content is reserved for EANS members and attendees of this event. Click here to become an EANS member and gain your access to the full content of the EANS Academy


Abstract
Discussion Forum (0)
Rate & Comment (0)
Introduction: Chronic subdural haematoma (CSDH) is a common neurosurgical pathology, but is approached with varying treatment algorithms. Research interest focused on this condition has been growing and the first international symposium on this topic took place at EANS Brussels, 2018.
Aim Our aim is to share outcomes from current CSDH studies and discuss areas lacking evidence, such that future collaborative studies can be designed.
Results: There is a growing interest on the pathophysiology and management of CSDH. We have already observed a broad variation in international and inter-hospital management of CSDH, due to lack of definitive evidence for many treatment options. On-going studies are focused on application of pharmacological agents (e.g. corticosteroids and tranexamic acid) and success of varying surgical techniques, such as the operative approach, irrigation and positioning of post-operative drains.
Conclusion: iCORIC (International COllaborative Research Initiative on Chronic subdural haematoma) has been established by members in the UK (British Neurosurgical Trainee Research Collaborative; BNTRC), the Netherlands (Dutch Subdural Hematoma Research group; DSHR), Denmark (the DAnish Cronic SUbdural Haematoma Study; DACSUHS), Sweden, Belgium, Switzerland, Colombia, India and Ethiopia. iCORIC is actively seeking interest from any other interested countries. The collaborative will meet annually at the EANS to share progress in current studies, set-up a collaborative databank of observational data in CSDH and plan future studies in CSDH. A consensus meeting to establish international guidance on CSDH management is planned for 2021, when many current trials will be completed.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings